Iovance Biotherapeutics, Inc.Iovance Biotherapeutics, Inc.Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc.

No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported −0.18 USD per share, beating the −0.17 USD estimate by −2.90%. Revenue for the same period reached ‪86.71 M‬ USD, despite the estimate of ‪80.71 M‬ USD. For the next quarter, analysts expect −0.14 USD in earnings per share and ‪82.55 M‬ USD in revenue.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise